当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析

恩华药业

(002262)

  

流通市值:216.82亿  总市值:249.17亿
流通股本:8.84亿   总股本:10.16亿

恩华药业(002262)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润11.05亿元,每股收益1.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益807555.67万元,未分配利润637008.48万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产907969.00万元,负债100413.33万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入4,470,988,804.693,010,121,701.841,510,888,789.075,697,633,044.59
营业总成本3,262,994,941.652,233,759,335.621,172,507,853.524,403,872,157.26
其他经营收益
营业利润1,245,304,994.17792,856,298.15338,602,094.11,336,573,612.01
利润总额1,233,557,232.01788,404,080.87336,331,153.341,296,688,433.42
净利润1,104,525,768.28700,054,285.99300,639,634.411,140,792,302.84
每股收益
其他综合收益----5,881,155.37
综合收益总额1,104,525,768.28700,054,285.99300,639,634.411,134,911,147.47
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计6,649,180,742.496,369,176,126.176,498,493,657.676,059,552,060.44
非流动资产:
非流动资产合计2,430,509,294.222,419,348,793.382,370,529,739.22,380,453,595.51
资产总计9,079,690,036.718,788,524,919.558,869,023,396.878,440,005,655.95
流动负债:
流动负债合计912,185,100.581,052,735,115.171,181,506,476.631,066,240,631.43
非流动负债:
非流动负债合计91,948,246.1890,768,427.7394,770,033.05100,249,246.74
负债合计1,004,133,346.761,143,503,542.91,276,276,509.681,166,489,878.17
所有者权益(或股东权益):
归属于母公司股东权益合计8,103,884,269.777,672,267,779.437,619,618,940.417,300,321,724.48
股东权益合计8,075,556,689.957,645,021,376.657,592,746,887.197,273,515,777.78
负债和股东权益合计9,079,690,036.718,788,524,919.558,869,023,396.878,440,005,655.95
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计4,928,567,517.593,180,488,495.511,551,415,504.056,014,764,208.71
经营活动现金流出小计4,017,420,960.642,685,665,296.191,232,143,204.585,098,637,705.65
经营活动产生的现金流量净额911,146,556.95494,823,199.32319,272,299.47916,126,503.06
投资活动产生的现金流量:
投资活动现金流入小计5,860,271,003.584,416,678,965.762,295,107,170.326,247,928,722.26
投资活动现金流出小计5,889,834,306.434,116,883,442.531,888,916,622.997,659,406,347.44
投资活动产生的现金流量净额-29,563,302.85299,795,523.23406,190,547.33-1,411,477,625.18
筹资活动产生的现金流量:
筹资活动现金流入小计40,000,00040,000,000-163,855,937
筹资活动现金流出小计450,077,661.04397,433,644.0812,398,245.97464,826,449.85
筹资活动产生的现金流量净额-410,077,661.04-357,433,644.08-12,398,245.97-300,970,512.85
汇率变动对现金及现金等价物的影响222,198.59524,324.56-136,359.25171,089.65
现金及现金等价物净增加额471,727,791.65437,709,403.03712,928,241.58-796,150,545.32
期末现金及现金等价物余额1,685,190,071.621,651,171,6831,926,390,521.551,213,462,279.97
补充资料:
现金及现金等价物的净增加额-437,709,403.03--796,150,545.32
最新报告期:2025-11-21
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,朱珂琛1.211.391.712025-11-21
中信建投袁清慧,贺菊颖1.241.421.662025-10-27
华西证券崔文亮,程仲瑶1.261.461.662025-10-27
华泰证券代雯,李奕玮1.241.391.632025-10-24
TOP↑